ISTH Congress Abstracts

Official abstracts site for the ISTH Congress

MENU 
  • Home
  • Congress Archive
    • ISTH 2022 Congress
    • ISTH 2021 Congress
    • ISTH 2020 Congress
  • Resources
  • Search

Is standard dose thromboprophylaxis (TP) as recommended by the Royal College of Obstetricians and Gynaecologists (RCOG) adequate in pregnancy for women with prior venous thrombo-embolism (VTE)?

E. Treharne1, A. Alexander2, E. Jackson2, B. Myers3

1University of Leicester Medical School, Leicester, United Kingdom, 2The University of Leicester Medical School, Leicester, United Kingdom, 3University Hospitals of Leicester, Leicester, United Kingdom

Abstract Number: LPB0143

Meeting: ISTH 2021 Congress

Theme: Women Health » Pregnancy and Pregnancy Complications

Background: Pregnancy-associated VTE is associated with a high morbidity rate, with pulmonary embolism (PE) a leading cause of maternal deaths. RCOG guidelines on prevention of VTE were updated in the guideline document “Reducing the Risk of Venous Thromboembolism during Pregnancy and the Puerperium” in 2015

Aims: Our aim, in this retrospective study, was to evaluate the utility of these guidelines in preventing recurrence of VTE in pregnancy.

Methods: We identified 290 pregnancies from our local data-base, 2015-2019, in whom a past VTE was recorded in 190.  For each record, we documented women’s characteristics and assessed whether appropriate thromboprophylaxis (TP) was used as recommended and if this prevented recurrence

Results: Appropriate weight-related thromboprophylaxis with Dalteparin had been used in all cases. Four cases had breakthrough VTEs (2.11%). Of these, one case had very poor compliance, a second had severe thrombotic tendency having antiphospholipid syndrome and Factor V Leiden heterozygosity. The third had a recurrence early in her 10th pregnancy at the time of confirmed pregnancy; therefore before TP was commenced. She later had post-partum thrombophlebitis despite recommended TP, although her compliance was poor. The final case had no extra risks to explain thromboprophylactic failure. Excluding cases 1 and 3, as these did not constitute TP failure, the frequency of recurrence was low (1%).

Conclusions: Frequency of VTE recurrence was low, in keeping with the New Zealand study, Cox et al, who reported 1.2% recurrence rate on TP with Enoxaparin. The Netherland study, van Lennep et al, using Nadroparin had 5.5% recurrence rate, but all cases were in ‘high-risk’ women, as in our 2nd case. Although we use low molecular weight heparins interchangeably there are differences in their half-lives and other characteristics which could also impact on recurrence risk. We conclude that for the vast majority of cases standard weight-adjusted TP is adequate for prevention of PA-VTE

To cite this abstract in AMA style:

Treharne E, Alexander A, Jackson E, Myers B. Is standard dose thromboprophylaxis (TP) as recommended by the Royal College of Obstetricians and Gynaecologists (RCOG) adequate in pregnancy for women with prior venous thrombo-embolism (VTE)? [abstract]. Res Pract Thromb Haemost. 2021; 5 (Suppl 2). https://abstracts.isth.org/abstract/is-standard-dose-thromboprophylaxis-tp-as-recommended-by-the-royal-college-of-obstetricians-and-gynaecologists-rcog-adequate-in-pregnancy-for-women-with-prior-venous-thrombo-embolism-vte/. Accessed October 1, 2023.

« Back to ISTH 2021 Congress

ISTH Congress Abstracts - https://abstracts.isth.org/abstract/is-standard-dose-thromboprophylaxis-tp-as-recommended-by-the-royal-college-of-obstetricians-and-gynaecologists-rcog-adequate-in-pregnancy-for-women-with-prior-venous-thrombo-embolism-vte/

Simple Search

Supported By:

Takeda logo

ISTH 2022 Congress site

Visit the official web site for the ISTH 2022 Virtual Congress »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2023 John Wiley & Sons, Inc. All Rights Reserved.
Wiley